LOW-GRADE SEROUS OVARIAN CANCER
Clinical trials for LOW-GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new LOW-GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for LOW-GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis Phase I trial tests a combination of two oral drugs, defactinib and VS-6766, in people with advanced solid tumors such as non-small cell lung cancer, low-grade serous ovarian cancer, and pancreatic cancer. The study aims to find the safest dose and evaluate how well the drug…
Matched conditions: LOW-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug cocktail targets tough ovarian cancer in japanese women
Disease control OngoingThis phase 2 study tests a combination of two drugs, avutometinib and defactinib, in 16 Japanese patients whose low-grade serous ovarian cancer has returned after platinum-based chemotherapy. The goal is to see if the combo can shrink tumors and how safe it is. The trial is activ…
Matched conditions: LOW-GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC